Bioceres Crop Solutions (BIOX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

BIOX Stock Forecast


Bioceres Crop Solutions stock forecast is as follows: an average price target of $13.30 (represents a 114.86% upside from BIOX’s last price of $6.19) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

BIOX Price Target


The average price target for Bioceres Crop Solutions (BIOX) is $13.30 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $12.50. This represents a potential 114.86% upside from BIOX's last price of $6.19.

BIOX Analyst Ratings


Buy

According to 3 Wall Street analysts, Bioceres Crop Solutions's rating consensus is 'Buy'. The analyst rating breakdown for BIOX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Bioceres Crop Solutions Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 21, 2024Kristen OwenOppenheimer$13.00$7.5173.10%110.02%
Sep 11, 2024Ben KlieveLoop Capital Markets$13.00$8.3156.36%110.02%
Sep 11, 2024Ben KlieveLake Street$13.00$8.6550.29%110.02%
Sep 11, 2024Austin MoellerCanaccord Genuity$12.50$8.3649.61%101.94%
Sep 10, 2024Kristen OwenOppenheimer$16.00$8.6584.97%158.48%
Jul 02, 2024Scott FortuneRoth Capital$15.00$11.1334.77%142.33%

The latest Bioceres Crop Solutions stock forecast, released on Oct 21, 2024 by Kristen Owen from Oppenheimer, set a price target of $13.00, which represents a 73.10% increase from the stock price at the time of the forecast ($7.51), and a 110.02% increase from BIOX last price ($6.19).

Bioceres Crop Solutions Price Target by Period


1M3M12M
# Anlaysts-16
Avg Price Target-$13.00$13.75
Last Closing Price$6.19$6.19$6.19
Upside/Downside-100.00%110.02%122.13%

In the current month, the average price target of Bioceres Crop Solutions stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Bioceres Crop Solutions's last price of $6.19. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 21, 2024OppenheimerOutperformOutperformHold
Sep 11, 2024Lake StreetBuyBuyHold
Sep 11, 2024Canaccord GenuityBuyBuyHold
Sep 10, 2024OppenheimerOutperformOutperformHold
Sep 30, 2022Canaccord GenuityBuyInitialise

Bioceres Crop Solutions's last stock rating was published by Oppenheimer on Oct 21, 2024. The company gave BIOX a "Outperform" rating, the same as its previous rate.

Bioceres Crop Solutions Financial Forecast


Bioceres Crop Solutions Revenue Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Revenue-------------$93.61M$94.55M$126.84M$105.75M$68.23M$92.31M$68.23M$81.05M$42.11M$48.00M$35.54M$48.13M$36.23M$62.27M
Avg Forecast$150.00M$105.00M$165.00M$130.00M$142.05M$83.45M$144.63M$110.03M$134.22M$98.50M$116.99M$123.82M$105.04M$88.41M$91.97M$81.99M$94.89M$44.62M$69.97M$52.57M$53.93M$26.52M$68.80M$40.00M$49.82M$20.00M$70.00M
High Forecast$162.27M$113.59M$178.49M$140.63M$153.67M$86.71M$150.43M$119.03M$134.22M$98.50M$132.81M$148.75M$113.63M$95.64M$99.50M$81.99M$94.89M$44.62M$69.97M$52.57M$53.93M$26.52M$68.80M$40.00M$49.82M$20.00M$70.00M
Low Forecast$137.41M$96.19M$151.15M$119.09M$130.13M$80.19M$138.82M$100.80M$134.22M$98.50M$101.62M$102.42M$96.23M$80.99M$84.26M$81.99M$94.89M$44.62M$69.97M$52.57M$53.93M$26.52M$68.80M$40.00M$49.82M$20.00M$70.00M
# Analysts111113322235221333444444443
Surprise %-------------1.06%1.03%1.55%1.11%1.53%1.32%1.30%1.50%1.59%0.70%0.89%0.97%1.81%0.89%

Bioceres Crop Solutions's average Quarter revenue forecast for Jun 23 based on 2 analysts is $105.04M, with a low forecast of $96.23M, and a high forecast of $113.63M. BIOX's average Quarter revenue forecast represents a 12.22% increase compared to the company's last Quarter revenue of $93.61M (Mar 23).

Bioceres Crop Solutions EBITDA Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts111113322235221333444444443
EBITDA-------------$29.49M$7.67M$20.62M$9.61M$4.49M$14.59M$4.49M$8.65M$9.15M$12.31M$6.02M$5.88M$9.83M$19.57M
Avg Forecast$22.13M$15.49M$24.34M$19.18M$20.96M$12.31M$21.34M$16.23M$19.80M$14.53M$17.26M$18.27M$15.50M$13.04M$13.57M$15.71M$18.18M$-1.29M$13.41M$10.07M$10.33M$6.88M$13.18M$7.66M$9.55M$1.30M$23.71M
High Forecast$23.94M$16.76M$26.33M$20.75M$22.67M$12.79M$22.19M$17.56M$19.80M$14.53M$19.59M$21.95M$16.76M$14.11M$14.68M$15.71M$18.18M$-1.03M$13.41M$10.07M$10.33M$8.26M$13.18M$7.66M$9.55M$1.56M$28.45M
Low Forecast$20.27M$14.19M$22.30M$17.57M$19.20M$11.83M$20.48M$14.87M$19.80M$14.53M$14.99M$15.11M$14.20M$11.95M$12.43M$15.71M$18.18M$-1.55M$13.41M$10.07M$10.33M$5.51M$13.18M$7.66M$9.55M$1.04M$18.97M
Surprise %-------------2.26%0.57%1.31%0.53%-3.48%1.09%0.45%0.84%1.33%0.93%0.79%0.62%7.57%0.83%

2 analysts predict BIOX's average Quarter EBITDA for Jun 23 to be $15.50M, with a high of $16.76M and a low of $14.20M. This is -47.45% lower than Bioceres Crop Solutions's previous annual EBITDA (Mar 23) of $29.49M.

Bioceres Crop Solutions Net Income Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts111113322235221333444444443
Net Income-------------$28.15M$-8.43M$3.91M$-4.68M$-6.98M$5.34M$-6.98M$1.38M$-6.37M$1.80M$-624.52K$3.14M$-7.98M$11.31M
Avg Forecast$12.58M$-1.26M$15.10M$1.89M$14.15M$-3.77M$9.28M$-1.38M$14.72M$10.69M$5.79M$5.66M$1.26M$-1.64M$4.40M$3.06M$12.69M$-3.89M$11.76M$5.61M$12.24M$-1.49M$18.18M$5.10M$13.72M$-3.69M$12.00M
High Forecast$13.92M$-1.12M$16.70M$2.09M$15.66M$1.08M$10.26M$-1.23M$14.91M$11.83M$8.27M$9.44M$1.39M$-1.46M$4.87M$3.06M$12.69M$-3.11M$11.76M$5.61M$12.24M$-1.19M$18.18M$5.10M$13.72M$-2.95M$14.40M
Low Forecast$11.21M$-1.39M$13.45M$1.68M$12.61M$-8.09M$8.27M$-1.53M$14.53M$9.53M$1.65M$2.83M$1.12M$-1.81M$3.92M$3.06M$12.69M$-4.67M$11.76M$5.61M$12.24M$-1.78M$18.18M$5.10M$13.72M$-4.43M$9.60M
Surprise %--------------17.21%-1.91%1.28%-0.37%1.79%0.45%-1.24%0.11%4.28%0.10%-0.12%0.23%2.16%0.94%

Bioceres Crop Solutions's average Quarter net income forecast for Jun 23 is $1.26M, with a range of $1.12M to $1.39M. BIOX's average Quarter net income forecast represents a -95.53% decrease compared to the company's last Quarter net income of $28.15M (Mar 23).

Bioceres Crop Solutions SG&A Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts111113322235221333444444443
SG&A-------------$23.99M$28.41M$24.95M$19.03M$18.03M$18.81M$18.03M$5.71M$8.20M$11.22M$10.21M$10.47M$8.68M$10.50M
Avg Forecast$28.23M$19.76M$31.05M$24.46M$26.73M$15.70M$27.22M$20.71M$25.26M$18.54M$22.02M$23.30M$19.77M$16.64M$17.31M$15.88M$18.38M$8.64M$13.55M$10.18M$10.44M$12.87M$13.32M$7.75M$9.65M$10.27M$11.13M
High Forecast$30.54M$21.38M$33.59M$26.47M$28.92M$16.32M$28.31M$22.40M$25.26M$18.54M$24.99M$27.99M$21.38M$18.00M$18.72M$15.88M$18.38M$8.64M$13.55M$10.18M$10.44M$15.44M$13.32M$7.75M$9.65M$12.32M$13.36M
Low Forecast$25.86M$18.10M$28.45M$22.41M$24.49M$15.09M$26.13M$18.97M$25.26M$18.54M$19.12M$19.27M$18.11M$15.24M$15.86M$15.88M$18.38M$8.64M$13.55M$10.18M$10.44M$10.29M$13.32M$7.75M$9.65M$8.21M$8.91M
Surprise %-------------1.44%1.64%1.57%1.04%2.09%1.39%1.77%0.55%0.64%0.84%1.32%1.09%0.85%0.94%

Bioceres Crop Solutions's average Quarter SG&A projection for Jun 23 is $19.77M, based on 2 Wall Street analysts, with a range of $18.11M to $21.38M. The forecast indicates a -17.59% fall compared to BIOX last annual SG&A of $23.99M (Mar 23).

Bioceres Crop Solutions EPS Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts111113322235221333444444443
EPS-------------$0.45$-0.14$0.06$-0.10$-0.17$0.13$-0.17$0.02$-0.18$0.02$-0.19$0.09$-0.22$0.31
Avg Forecast$0.20$-0.02$0.24$0.03$0.23$-0.06$0.15$-0.02$0.23$0.17$0.09$0.09$0.02$-0.03$0.07$0.05$0.20$-0.08$0.18$0.09$0.19$-0.04$0.28$0.08$0.21$-0.12$0.33
High Forecast$0.22$-0.02$0.27$0.03$0.25$0.02$0.16$-0.02$0.24$0.19$0.13$0.15$0.02$-0.02$0.08$0.05$0.20$-0.08$0.18$0.09$0.19$-0.04$0.28$0.08$0.21$-0.12$0.33
Low Forecast$0.18$-0.02$0.21$0.03$0.20$-0.13$0.13$-0.02$0.23$0.15$0.03$0.04$0.02$-0.03$0.06$0.05$0.20$-0.08$0.18$0.09$0.19$-0.04$0.28$0.08$0.21$-0.12$0.33
Surprise %--------------17.31%-2.00%1.35%-0.50%2.17%0.71%-1.93%0.11%4.44%0.06%-2.38%0.40%1.91%0.94%

According to 2 Wall Street analysts, Bioceres Crop Solutions's projected average Quarter EPS for Jun 23 is $0.02, with a low estimate of $0.02 and a high estimate of $0.02. This represents a -95.56% decrease compared to BIOX previous annual EPS of $0.45 (Mar 23).

Bioceres Crop Solutions Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AVDAmerican Vanguard$4.59$20.00335.73%Buy
BIOXBioceres Crop Solutions$6.80$13.3095.59%Buy
ICLICL Group$4.97$7.0742.25%Hold
LVROLavoro$5.01$7.0039.72%Buy
FMCFMC$51.70$69.5034.43%Buy
MOSMosaic Company$25.44$34.1734.32%Buy
IPIIntrepid Potash$23.82$31.5032.24%Hold
CTVACorteva$58.57$66.8014.05%Buy
CFCF Industries$86.68$87.000.37%Buy

BIOX Forecast FAQ


Is Bioceres Crop Solutions a good buy?

Yes, according to 3 Wall Street analysts, Bioceres Crop Solutions (BIOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of BIOX's total ratings.

What is BIOX's price target?

Bioceres Crop Solutions (BIOX) average price target is $13.3 with a range of $12.5 to $15, implying a 114.86% from its last price of $6.19. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Bioceres Crop Solutions stock go up soon?

According to Wall Street analysts' prediction for BIOX stock, the company can go up by 114.86% (from the last price of $6.19 to the average price target of $13.3), up by 142.33% based on the highest stock price target, and up by 101.94% based on the lowest stock price target.

Can Bioceres Crop Solutions stock reach $9?

BIOX's average twelve months analyst stock price target of $13.3 supports the claim that Bioceres Crop Solutions can reach $9 in the near future.

What are Bioceres Crop Solutions's analysts' financial forecasts?

Bioceres Crop Solutions's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $480.15M (high $509.83M, low $449.94M), average EBITDA is $70.84M (high $75.21M, low $66.38M), average net income is $18.27M (high $25.77M, low $11.26M), average SG&A $90.36M (high $95.94M, low $84.67M), and average EPS is $0.29 (high $0.41, low $0.179). BIOX's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $550M (high $594.98M, low $503.85M), average EBITDA is $81.14M (high $87.78M, low $74.33M), average net income is $28.3M (high $31.59M, low $24.95M), average SG&A $103.5M (high $111.97M, low $94.82M), and average EPS is $0.45 (high $0.502, low $0.397).

Did the BIOX's actual financial results beat the analysts' financial forecasts?

Based on Bioceres Crop Solutions's last annual report (Jun 2022), the company's revenue was $328.46M, beating the average analysts forecast of $262.06M by 25.34%. Apple's EBITDA was $49.33M, beating the average prediction of $40.37M by 22.18%. The company's net income was $-3.909M, missing the average estimation of $26.17M by -114.94%. Apple's SG&A was $58.18M, beating the average forecast of $50.75M by 14.64%. Lastly, the company's EPS was $-0.0924, missing the average prediction of $0.393 by -123.52%. In terms of the last quarterly report (Mar 2023), Bioceres Crop Solutions's revenue was $93.61M, beating the average analysts' forecast of $88.41M by 5.87%. The company's EBITDA was $29.49M, beating the average prediction of $13.04M by 126.08%. Bioceres Crop Solutions's net income was $28.15M, missing the average estimation of $-1.635M by -1821.04%. The company's SG&A was $23.99M, beating the average forecast of $16.64M by 44.17%. Lastly, the company's EPS was $0.45, missing the average prediction of $-0.026 by -1830.77%